Skip to content

Clinical trials

Thrombotic Microangiopathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombotic Microangiopathies Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20131
20142
20183
20203
20214
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Recruiting3
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.6
Omeros Corporation3
Children's Hospital Medical Center, Cincinnati2
AKARI Therapeutics1
Archemix Corp.1
Brigham and Women's Hospital1
Hutchmed1
Northwell Health1
Novartis Pharmaceuticals1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombotic Microangiopathies19
Atypical Hemolytic Uremic Syndrome5
Acute Kidney Injury2
Purpura, Thrombotic Thrombocytopenic2
Thrombocytopenia2
Anemia, Hemolytic1
Autoimmune Diseases1
Blood Coagulation Disorders1
Blood Platelet Disorders1
Bronchiolitis Obliterans1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.